TARGETING THE T‐CELL RECEPTOR Β‐CONSTANT DOMAIN FOR IMMUNOTHERAPY OF T‐CELL MALIGNANCIES. (June 2017) - Maciocia, P.M.; Wawrzyniecka, P.; Philip, B.; Ricciardelli, I.; Akarca, A.; Onohua, S.; Cole, D.; Sewell, A.; Peggs, K.; Linch, D.; Marafioti, T.; Pule, M.